APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Valsartan Capsules Market Analysis and Forecast 2026-2032

29 December 2025193 pages

Choose your research edition.

Industry ResearchValsartan Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Capsules Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Valsartan Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Capsules Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Valsartan Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Valsartan Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Valsartan Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Valsartan Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Valsartan Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Valsartan Capsules include Conquer, Dynemed, Mylan, Lepu Medical, Cisen Pharmaceutical, Torrent Pharmaceuticals, Teva Pharmaceutical Industries, Sun Pharmaceutical and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Valsartan Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Valsartan Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Valsartan Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Valsartan Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Valsartan Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Valsartan Capsules sales, projected growth trends, production technology, application and end-user industry.

Valsartan Capsules Segment by Company

Conquer

Dynemed

Mylan

Lepu Medical

Cisen Pharmaceutical

Torrent Pharmaceuticals

Teva Pharmaceutical Industries

Sun Pharmaceutical

Novartis

Valsartan Capsules Segment by Type

160 Mg

40 Mg

80 Mg

Others

Valsartan Capsules Segment by Application

Treatment of Hypertension

Treatment of Heart Disease

Others

Valsartan Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Valsartan Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Valsartan Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valsartan Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Valsartan Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 160 Mg Major Manufacturers Table 3. 40 Mg Major Manufacturers Table 4. 80 Mg Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Valsartan Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Treatment of Hypertension Major Manufacturers Table 8. Treatment of Heart Disease Major Manufacturers Table 9. Others Major Manufacturers Table 10. Valsartan Capsules Industry Trends Table 11. Valsartan Capsules Industry Drivers Table 12. Valsartan Capsules Industry Opportunities and Challenges Table 13. Valsartan Capsules Industry Restraints Table 14. Global Valsartan Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Valsartan Capsules Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Valsartan Capsules Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Valsartan Capsules Revenue Market Share by Region (2021-2026) Table 18. Global Valsartan Capsules Revenue Market Share by Region (2027-2032) Table 19. Global Valsartan Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Valsartan Capsules Sales by Region (2021-2026) & (K Units) Table 21. Global Valsartan Capsules Sales by Region (2027-2032) & (K Units) Table 22. Global Valsartan Capsules Sales Market Share by Region (2021-2026) Table 23. Global Valsartan Capsules Sales Market Share by Region (2027-2032) Table 24. Global Valsartan Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Valsartan Capsules Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Valsartan Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Valsartan Capsules Sales Market Share by Manufacturers (2021-2026) Table 28. Global Valsartan Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Valsartan Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Valsartan Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Valsartan Capsules Manufacturers, Product Type & Application Table 32. Global Valsartan Capsules Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Valsartan Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Valsartan Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Valsartan Capsules Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Valsartan Capsules Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Valsartan Capsules Revenue Market Share by Type (2021-2026) Table 39. Global Valsartan Capsules Revenue Market Share by Type (2027-2032) Table 40. Global Valsartan Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 42. Global Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 43. Global Valsartan Capsules Sales Market Share by Type (2021-2026) Table 44. Global Valsartan Capsules Sales Market Share by Type (2027-2032) Table 45. Global Valsartan Capsules Price by Type (2021-2026) & (US$/Unit) Table 46. Global Valsartan Capsules Price by Type (2027-2032) & (US$/Unit) Table 47. Global Valsartan Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Valsartan Capsules Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Valsartan Capsules Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Valsartan Capsules Revenue Market Share by Application (2021-2026) Table 51. Global Valsartan Capsules Revenue Market Share by Application (2027-2032) Table 52. Global Valsartan Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 54. Global Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 55. Global Valsartan Capsules Sales Market Share by Application (2021-2026) Table 56. Global Valsartan Capsules Sales Market Share by Application (2027-2032) Table 57. Global Valsartan Capsules Price by Application (2021-2026) & (US$/Unit) Table 58. Global Valsartan Capsules Price by Application (2027-2032) & (US$/Unit) Table 59. Conquer Company Information Table 60. Conquer Business Overview Table 61. Conquer Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Conquer Valsartan Capsules Product Portfolio Table 63. Conquer Recent Development Table 64. Dynemed Company Information Table 65. Dynemed Business Overview Table 66. Dynemed Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Dynemed Valsartan Capsules Product Portfolio Table 68. Dynemed Recent Development Table 69. Mylan Company Information Table 70. Mylan Business Overview Table 71. Mylan Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mylan Valsartan Capsules Product Portfolio Table 73. Mylan Recent Development Table 74. Lepu Medical Company Information Table 75. Lepu Medical Business Overview Table 76. Lepu Medical Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lepu Medical Valsartan Capsules Product Portfolio Table 78. Lepu Medical Recent Development Table 79. Cisen Pharmaceutical Company Information Table 80. Cisen Pharmaceutical Business Overview Table 81. Cisen Pharmaceutical Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Cisen Pharmaceutical Valsartan Capsules Product Portfolio Table 83. Cisen Pharmaceutical Recent Development Table 84. Torrent Pharmaceuticals Company Information Table 85. Torrent Pharmaceuticals Business Overview Table 86. Torrent Pharmaceuticals Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Torrent Pharmaceuticals Valsartan Capsules Product Portfolio Table 88. Torrent Pharmaceuticals Recent Development Table 89. Teva Pharmaceutical Industries Company Information Table 90. Teva Pharmaceutical Industries Business Overview Table 91. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio Table 93. Teva Pharmaceutical Industries Recent Development Table 94. Sun Pharmaceutical Company Information Table 95. Sun Pharmaceutical Business Overview Table 96. Sun Pharmaceutical Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sun Pharmaceutical Valsartan Capsules Product Portfolio Table 98. Sun Pharmaceutical Recent Development Table 99. Novartis Company Information Table 100. Novartis Business Overview Table 101. Novartis Valsartan Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Novartis Valsartan Capsules Product Portfolio Table 103. Novartis Recent Development Table 104. North America Valsartan Capsules Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Valsartan Capsules Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 107. North America Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 108. North America Valsartan Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 109. North America Valsartan Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 110. North America Valsartan Capsules Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Valsartan Capsules Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 113. North America Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 114. North America Valsartan Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 115. North America Valsartan Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 116. North America Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Valsartan Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Valsartan Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. North America Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 121. North America Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 122. North America Valsartan Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 123. North America Valsartan Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 124. United States Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 125. Canada Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 126. Mexico Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 127. Europe Valsartan Capsules Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Valsartan Capsules Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 130. Europe Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 131. Europe Valsartan Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Europe Valsartan Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Europe Valsartan Capsules Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Valsartan Capsules Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 136. Europe Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 137. Europe Valsartan Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Europe Valsartan Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Europe Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Valsartan Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Valsartan Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Europe Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 144. Europe Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 145. Europe Valsartan Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Europe Valsartan Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Germany Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 148. France Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 149. U.K. Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 150. Italy Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 151. Russia Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 152. Spain Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 154. Switzerland Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 155. Sweden Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 156. Poland Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 157. China Valsartan Capsules Revenue by Type (2021-2026) & (US$ Million) Table 158. China Valsartan Capsules Revenue by Type (2027-2032) & (US$ Million) Table 159. China Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 160. China Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 161. China Valsartan Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 162. China Valsartan Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 163. China Valsartan Capsules Revenue by Application (2021-2026) & (US$ Million) Table 164. China Valsartan Capsules Revenue by Application (2027-2032) & (US$ Million) Table 165. China Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 166. China Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 167. China Valsartan Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 168. China Valsartan Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Valsartan Capsules Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Valsartan Capsules Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 172. Asia Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 173. Asia Valsartan Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 174. Asia Valsartan Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 175. Asia Valsartan Capsules Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Valsartan Capsules Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 178. Asia Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 179. Asia Valsartan Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 180. Asia Valsartan Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Asia Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Valsartan Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Valsartan Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. Asia Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 186. Asia Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 187. Asia Valsartan Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 188. Asia Valsartan Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Japan Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 190. South Korea Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 191. India Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 192. Australia Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 193. Taiwan Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Valsartan Capsules Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Valsartan Capsules Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 198. SAMEA Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 199. SAMEA Valsartan Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 200. SAMEA Valsartan Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 201. SAMEA Valsartan Capsules Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Valsartan Capsules Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 204. SAMEA Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 205. SAMEA Valsartan Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 206. SAMEA Valsartan Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 207. SAMEA Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Valsartan Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Valsartan Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 211. SAMEA Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 212. SAMEA Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 213. SAMEA Valsartan Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 214. SAMEA Valsartan Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Brazil Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 216. Argentina Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 217. Chile Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 218. Colombia Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 219. Peru Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 221. Israel Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 222. UAE Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 223. Turkey Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 224. Iran Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 225. Egypt Valsartan Capsules Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Valsartan Capsules Distributors List Table 229. Valsartan Capsules Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Valsartan Capsules Image Figure 2. Global Valsartan Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 160 Mg Image Figure 5. 40 Mg Image Figure 6. 80 Mg Image Figure 7. Others Image Figure 8. Global Valsartan Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Valsartan Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 10. Treatment of Hypertension Image Figure 11. Treatment of Heart Disease Image Figure 12. Others Image Figure 13. Global Valsartan Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Capsules Revenue (2021-2032) & (US$ Million) Figure 15. Global Valsartan Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Valsartan Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Valsartan Capsules Revenue Market Share by Region (2021-2032) Figure 18. Global Valsartan Capsules Sales (2021-2032) & (K Units) Figure 19. Global Valsartan Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Valsartan Capsules Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Valsartan Capsules Sales YoY (2021-2032) & (K Units) Figure 22. Europe Valsartan Capsules Sales YoY (2021-2032) & (K Units) Figure 23. China Valsartan Capsules Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Valsartan Capsules Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Valsartan Capsules Sales YoY (2021-2032) & (K Units) Figure 26. Global Valsartan Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Valsartan Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Valsartan Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Valsartan Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Valsartan Capsules Revenue Market Share by Type (2021-2032) Figure 32. Global Valsartan Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Valsartan Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Valsartan Capsules Sales Market Share by Type (2021-2032) Figure 35. Global Valsartan Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Valsartan Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Valsartan Capsules Revenue Market Share by Application (2021-2032) Figure 38. Global Valsartan Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Valsartan Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Valsartan Capsules Sales Market Share by Application (2021-2032) Figure 41. North America Valsartan Capsules Revenue Share by Type (2021-2032) Figure 42. North America Valsartan Capsules Sales Share by Type (2021-2032) Figure 43. North America Valsartan Capsules Revenue Share by Application (2021-2032) Figure 44. North America Valsartan Capsules Sales Share by Application (2021-2032) Figure 45. North America Valsartan Capsules Revenue Share by Country (2021-2032) Figure 46. North America Valsartan Capsules Sales Share by Country (2021-2032) Figure 47. Europe Valsartan Capsules Revenue Share by Type (2021-2032) Figure 48. Europe Valsartan Capsules Sales Share by Type (2021-2032) Figure 49. Europe Valsartan Capsules Revenue Share by Application (2021-2032) Figure 50. Europe Valsartan Capsules Sales Share by Application (2021-2032) Figure 51. Europe Valsartan Capsules Revenue Share by Country (2021-2032) Figure 52. Europe Valsartan Capsules Sales Share by Country (2021-2032) Figure 53. China Valsartan Capsules Revenue Share by Type (2021-2032) Figure 54. China Valsartan Capsules Sales Share by Type (2021-2032) Figure 55. China Valsartan Capsules Revenue Share by Application (2021-2032) Figure 56. China Valsartan Capsules Sales Share by Application (2021-2032) Figure 57. Asia Valsartan Capsules Revenue Share by Type (2021-2032) Figure 58. Asia Valsartan Capsules Sales Share by Type (2021-2032) Figure 59. Asia Valsartan Capsules Revenue Share by Application (2021-2032) Figure 60. Asia Valsartan Capsules Sales Share by Application (2021-2032) Figure 61. Asia Valsartan Capsules Revenue Share by Country (2021-2032) Figure 62. Asia Valsartan Capsules Sales Share by Country (2021-2032) Figure 63. SAMEA Valsartan Capsules Revenue Share by Type (2021-2032) Figure 64. SAMEA Valsartan Capsules Sales Share by Type (2021-2032) Figure 65. SAMEA Valsartan Capsules Revenue Share by Application (2021-2032) Figure 66. SAMEA Valsartan Capsules Sales Share by Application (2021-2032) Figure 67. SAMEA Valsartan Capsules Revenue Share by Country (2021-2032) Figure 68. SAMEA Valsartan Capsules Sales Share by Country (2021-2032) Figure 69. Valsartan Capsules Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Valsartan Capsules Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 160 Mg
  • 40 Mg
  • 80 Mg
  • Others
Applications
  • Treatment of Hypertension
  • Treatment of Heart Disease
  • Others
Companies covered
  • Conquer
  • Dynemed
  • Mylan
  • Lepu Medical
  • Cisen Pharmaceutical
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Valsartan Capsules Market by Type
  3. 1.2.1 Global Valsartan Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 160 Mg
  5. 1.2.3 40 Mg
  6. 1.2.4 80 Mg
  7. 1.2.5 Others
  8. 1.3 Valsartan Capsules Market by Application
  9. 1.3.1 Global Valsartan Capsules Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Treatment of Hypertension
  11. 1.3.3 Treatment of Heart Disease
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Valsartan Capsules Market Dynamics
  1. 2.1 Valsartan Capsules Industry Trends
  2. 2.2 Valsartan Capsules Industry Drivers
  3. 2.3 Valsartan Capsules Industry Opportunities and Challenges
  4. 2.4 Valsartan Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Valsartan Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Valsartan Capsules Revenue by Region
  3. 3.2.1 Global Valsartan Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Valsartan Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Valsartan Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Valsartan Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Valsartan Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Valsartan Capsules Sales by Region
  9. 3.4.1 Global Valsartan Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Valsartan Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Valsartan Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Valsartan Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Valsartan Capsules Revenue by Manufacturers
  2. 4.1.1 Global Valsartan Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Valsartan Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Valsartan Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Valsartan Capsules Sales by Manufacturers
  6. 4.2.1 Global Valsartan Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Valsartan Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Valsartan Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Valsartan Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Valsartan Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Valsartan Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Valsartan Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Valsartan Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Valsartan Capsules Market CR5 and HHI
  16. 4.8.2 2025 Valsartan Capsules Tier 1, Tier 2, and Tier 3
5 Valsartan Capsules Market by Type
  1. 5.1 Global Valsartan Capsules Revenue by Type
  2. 5.1.1 Global Valsartan Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Valsartan Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Valsartan Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Valsartan Capsules Sales by Type
  6. 5.2.1 Global Valsartan Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Valsartan Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Valsartan Capsules Price by Type
6 Valsartan Capsules Market by Application
  1. 6.1 Global Valsartan Capsules Revenue by Application
  2. 6.1.1 Global Valsartan Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Valsartan Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Valsartan Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Valsartan Capsules Sales by Application
  6. 6.2.1 Global Valsartan Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Valsartan Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Valsartan Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Valsartan Capsules Price by Application
7 Company Profiles
  1. 7.1 Conquer
  2. 7.1.1 Conquer Company Information
  3. 7.1.2 Conquer Business Overview
  4. 7.1.3 Conquer Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Conquer Valsartan Capsules Product Portfolio
  6. 7.1.5 Conquer Recent Developments
  7. 7.2 Dynemed
  8. 7.2.1 Dynemed Company Information
  9. 7.2.2 Dynemed Business Overview
  10. 7.2.3 Dynemed Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dynemed Valsartan Capsules Product Portfolio
  12. 7.2.5 Dynemed Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Valsartan Capsules Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Lepu Medical
  20. 7.4.1 Lepu Medical Company Information
  21. 7.4.2 Lepu Medical Business Overview
  22. 7.4.3 Lepu Medical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lepu Medical Valsartan Capsules Product Portfolio
  24. 7.4.5 Lepu Medical Recent Developments
  25. 7.5 Cisen Pharmaceutical
  26. 7.5.1 Cisen Pharmaceutical Company Information
  27. 7.5.2 Cisen Pharmaceutical Business Overview
  28. 7.5.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cisen Pharmaceutical Valsartan Capsules Product Portfolio
  30. 7.5.5 Cisen Pharmaceutical Recent Developments
  31. 7.6 Torrent Pharmaceuticals
  32. 7.6.1 Torrent Pharmaceuticals Company Information
  33. 7.6.2 Torrent Pharmaceuticals Business Overview
  34. 7.6.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Torrent Pharmaceuticals Valsartan Capsules Product Portfolio
  36. 7.6.5 Torrent Pharmaceuticals Recent Developments
  37. 7.7 Teva Pharmaceutical Industries
  38. 7.7.1 Teva Pharmaceutical Industries Company Information
  39. 7.7.2 Teva Pharmaceutical Industries Business Overview
  40. 7.7.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio
  42. 7.7.5 Teva Pharmaceutical Industries Recent Developments
  43. 7.8 Sun Pharmaceutical
  44. 7.8.1 Sun Pharmaceutical Company Information
  45. 7.8.2 Sun Pharmaceutical Business Overview
  46. 7.8.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharmaceutical Valsartan Capsules Product Portfolio
  48. 7.8.5 Sun Pharmaceutical Recent Developments
  49. 7.9 Novartis
  50. 7.9.1 Novartis Company Information
  51. 7.9.2 Novartis Business Overview
  52. 7.9.3 Novartis Valsartan Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Novartis Valsartan Capsules Product Portfolio
  54. 7.9.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Valsartan Capsules Market Size by Type
  2. 8.1.1 North America Valsartan Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Valsartan Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Valsartan Capsules Price by Type (2021-2032)
  5. 8.2 North America Valsartan Capsules Market Size by Application
  6. 8.2.1 North America Valsartan Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Valsartan Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Valsartan Capsules Price by Application (2021-2032)
  9. 8.3 North America Valsartan Capsules Market Size by Country
  10. 8.3.1 North America Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Valsartan Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Valsartan Capsules Market Size by Type
  2. 9.1.1 Europe Valsartan Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Valsartan Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Valsartan Capsules Price by Type (2021-2032)
  5. 9.2 Europe Valsartan Capsules Market Size by Application
  6. 9.2.1 Europe Valsartan Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Valsartan Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Valsartan Capsules Price by Application (2021-2032)
  9. 9.3 Europe Valsartan Capsules Market Size by Country
  10. 9.3.1 Europe Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Valsartan Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Valsartan Capsules Market Size by Type
  2. 10.1.1 China Valsartan Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Valsartan Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Valsartan Capsules Price by Type (2021-2032)
  5. 10.2 China Valsartan Capsules Market Size by Application
  6. 10.2.1 China Valsartan Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Valsartan Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Valsartan Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Valsartan Capsules Market Size by Type
  2. 11.1.1 Asia Valsartan Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Valsartan Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Valsartan Capsules Price by Type (2021-2032)
  5. 11.2 Asia Valsartan Capsules Market Size by Application
  6. 11.2.1 Asia Valsartan Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Valsartan Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Valsartan Capsules Price by Application (2021-2032)
  9. 11.3 Asia Valsartan Capsules Market Size by Country
  10. 11.3.1 Asia Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Valsartan Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Valsartan Capsules Market Size by Type
  2. 12.1.1 SAMEA Valsartan Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Valsartan Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Valsartan Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Valsartan Capsules Market Size by Application
  6. 12.2.1 SAMEA Valsartan Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Valsartan Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Valsartan Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Valsartan Capsules Market Size by Country
  10. 12.3.1 SAMEA Valsartan Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Valsartan Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Valsartan Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Valsartan Capsules Value Chain Analysis
  2. 13.1.1 Valsartan Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Valsartan Capsules Production Mode & Process
  6. 13.2 Valsartan Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Valsartan Capsules Distributors
  9. 13.2.3 Valsartan Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst